Which hedge funds own IBRX? IMMUNITYBIO INC, Q2 2026 13F holders
10 of the hedge funds tracked by WhaleCreep disclosed a position in IBRX (IMMUNITYBIO INC) in their Q2 2026 13F filings, worth $187.2m in total. The largest holder by portfolio weight is Woodline Partners at 0.1% of its book. 2 managers opened a new position this quarter: Renaissance Technologies LLC, First Manhattan.
10tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold IBRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.1% | $21.9m | 2,500,189 | -27% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $101.1m | 11,551,019 | -8% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $48.9m | 5,579,793 | 293% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $9.0m | 1,029,399 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $751.7k | 85,857 | 52% | added |
| Sculptor Capital Management | Q2 2026 | 0.0% | $693.4k | 79,200 | -11% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $175.1k | 20,000 | 0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $3.4m | 387,700 | 403% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $1.2m | 136,045 | -55% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $87.5k | 10,000 | – | new |
How has hedge fund ownership of IBRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $187.2m |
| Q1 2026 | 9 | $142.4m |
| Q4 2025 | 3 | $9.3m |
| Q3 2025 | 3 | $15.6m |
| Q2 2025 | 3 | $9.2m |
| Q1 2025 | 2 | $10.4m |
| Q4 2024 | 1 | $8.8m |
| Q3 2024 | 1 | $1.6m |
| Q2 2024 | 2 | $3.4m |
| Q3 2023 | 1 | $26.2k |
| Q1 2023 | 2 | $551.5k |
| Q2 2022 | 2 | $1.8m |
| Q4 2021 | 1 | $1.9m |
| Q3 2021 | 1 | $2.0m |
Counts every tracked manager that disclosed IBRX in that quarter's filing, including managers that have since stopped filing.